Importantly, this study reveals that KMT5A-mediated SNIP1 K301 methylation not only serves as a key signal driving c-MYC hyper-activation and cancer metastasis, but also acts as a marker of poor prognosis of TNBC patients. Here, KMT5A is linked to cancer.